Thrivent Financial for Lutherans’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.02M | Sell |
|
|||||
|
2025
Q1 | $9.91M | Sell |
|
|||||
|
2024
Q4 | $9.45M | Buy |
|
|||||
|
2024
Q3 | $6.04M | Buy |
|
|||||
|
2024
Q2 | $4.63M | Sell |
|
|||||
|
2024
Q1 | $6.72M | Sell |
|
|||||
|
2023
Q4 | $10.9M | Sell |
|
|||||
|
2023
Q3 | $14.6M | Sell |
|
|||||
|
2023
Q2 | $19.9M | Sell |
|
|||||
|
2023
Q1 | $22.8M | Buy |
|
|||||
|
2022
Q4 | $23.6M | Buy |
|
|||||
|
2022
Q3 | $9.61M | Sell |
|
|||||
|
2022
Q2 | $10.5M | Sell |
|
|||||
|
2022
Q1 | $11.4M | Buy |
|
|||||
|
2021
Q4 | $9.77M | Buy |
|
|||||
|
2021
Q3 | $8.87M | Buy |
|
|||||
|
2021
Q2 | $9.38M | Sell |
|
|||||
|
2021
Q1 | $8.86M | Buy |
|
|||||
|
2020
Q4 | $8.29M | Buy |
|
|||||
|
2020
Q3 | $7.81M | Buy |
|
|||||
|
2020
Q2 | $6.88M | Sell |
|
|||||
|
2020
Q1 | $6.68M | Sell |
|
|||||
|
2019
Q4 | $7.92M | Buy |
|
|||||
|
2019
Q3 | $4.38M | Buy |
|
|||||
|
2019
Q2 | $3.65M | Sell |
|
|||||
|
2019
Q1 | $7.44M | Sell |
|
|||||
|
2018
Q4 | $8.84M | Buy |
|
|||||
|
2018
Q3 | $5.04M | Buy |
|
|||||
|
2018
Q2 | $4.41M | Sell |
|
|||||
|
2018
Q1 | $5.07M | Sell |
|
|||||
|
2017
Q4 | $4.98M | Buy |
|
|||||
|
2017
Q3 | $4.96M | Buy |
|
|||||
|
2017
Q2 | $3.68M | Sell |
|
|||||
|
2017
Q1 | $123M | Buy |
|
|||||
|
2016
Q4 | $16M | Buy |
|
|||||
|
2016
Q3 | $6.2M | Buy |
|
|||||
|
2016
Q2 | $8.33M | Buy |
|
|||||
|
2016
Q1 | $7.11M | Buy |
|
|||||
|
2015
Q4 | $3.71M | Buy |
|
|||||
|
2015
Q3 | $2.7M | Sell |
|
|||||
|
2015
Q2 | $3.32M | Buy |
|
|||||
|
2015
Q1 | $3.06M | Buy |
|
|||||
|
2014
Q4 | $2.72M | Buy |
|
|||||
|
2014
Q3 | $2.21M | Buy |
|
|||||
|
2014
Q2 | $1.89M | Sell |
|
|||||
|
2014
Q1 | $2.21M | Buy |
|
|||||
|
2013
Q4 | $2.26M | Buy |
|
|||||
|
2013
Q3 | $1.77M | Sell |
|
|||||
|
2013
Q2 | $6.03K | Buy |
|